The Hitchhikers Guide to Cancer Stem Cell Theory: Markers, Pathways and Therapy

被引:36
作者
Fabian, Akos [1 ]
Vereb, Gyoergy [1 ,2 ]
Szoellosi, Janos [1 ,2 ]
机构
[1] Univ Debrecen, Dept Biophys & Cell Biol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
[2] Univ Debrecen, MTA Cell Biol & Signaling Res Grp, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
关键词
cancer stem cells; cancer stem cell markers; cancer stem cell niche; therapy resistance; CIRCULATING TUMOR-CELLS; ACUTE MYELOID-LEUKEMIA; HEPATOCELLULAR-CARCINOMA CELLS; TUMORIGENIC MELANOMA-CELLS; ALDEHYDE DEHYDROGENASE 1; BREAST-CANCER; PROSTATE-CANCER; SELF-RENEWAL; PANCREATIC-CANCER; SIDE POPULATION;
D O I
10.1002/cyto.a.22206
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cancer stem cell (CSC) biology is a rapidly developing field within cancer research. CSCs are postulated to be a unique cell population exclusively capable of infinite self renewal, multilineage differentiation and with ability to evade conventional cytotoxic cancer therapy. These traits distinguish CSCs from their more differentiated counterparts, which possess only limited or no potential for self renewal and tumor initiation. Therefore, CSCs would be the driving motor of malignant growth and therapy resistance. Accordingly, successful cancer treatment would need to eliminate this highly potent group of cells, since even small residual numbers would suffice to recapitulate the disease after therapy. Putative CSCs has been identified in a broad range of human malignancies and several cell surface markers have been associated with their stem cell phenotype. Despite all efforts, a pure CSC population has not been isolated and often in vitro clonogenic and in vivo tumorigenic potential is found in several cell populations with occasionally contradictory surface marker signatures. Here, we give a brief overview of recent advances in CSC theory, including the signaling pathways in CSCs that also appear crucial for stem cells homeostasis in normal tissues. We discuss evidence for the interaction of CSCs with the stromal tumor environment. Finally, we review the emerging potentially effective CSC-targeted treatment strategies and their future role in therapy. (C) 2012 International Society for Advancement of Cytometry
引用
收藏
页码:62 / 71
页数:10
相关论文
共 185 条
[1]   Disruption of a Quorum Sensing mechanism triggers tumorigenesis: a simple discrete model corroborated by experiments in mammary cancer stem cells [J].
Agur, Zvia ;
Kogan, Yuri ;
Levi, Liora ;
Harrison, Hannah ;
Lamb, Rebecca ;
Kirnasovsky, Oleg U. ;
Clarke, Robert B. .
BIOLOGY DIRECT, 2010, 5
[2]   Therapeutic implications of cancer stem cells [J].
Al-Hajj, M ;
Becker, MW ;
Wichal, M ;
Weissman, I ;
Clarke, MF .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2004, 14 (01) :43-47
[3]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[4]   Hypoxia-induced dedifferentiation of tumor cells -: A mechanism behind heterogeneity and aggressiveness of solid tumors [J].
Axelson, H ;
Fredlund, E ;
Ovenberger, M ;
Landberg, G ;
Påhlman, S .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2005, 16 (4-5) :554-563
[5]   Differentiation Therapy: Targeting Human Renal Cancer Stem Cells with Interleukin 15 [J].
Azzi, Sandy ;
Bruno, Stefania ;
Giron-Michel, Julien ;
Clay, Denis ;
Devocelle, Aurore ;
Croce, Michela ;
Ferrini, Silvano ;
Chouaib, Salem ;
Vazquez, Aime ;
Charpentier, Bernard ;
Camussi, Giovanni ;
Azzarone, Bruno ;
Eid, Pierre .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (24) :1884-1898
[6]   Epigenetic regulation of CD133 and tumorigenicity of CD133+ovarian cancer cells [J].
Baba, T. ;
Convery, P. A. ;
Matsumura, N. ;
Whitaker, R. S. ;
Kondoh, E. ;
Perry, T. ;
Huang, Z. ;
Bentley, R. C. ;
Mori, S. ;
Fujii, S. ;
Marks, J. R. ;
Berchuck, A. ;
Murphy, S. K. .
ONCOGENE, 2009, 28 (02) :209-218
[7]  
Bae KM, 2011, AM J CANCER RES, V1, P71
[8]   ABCG2 is Required to Control the Sonic Hedgehog Pathway in Side Population Cells with Stem-like Properties [J].
Balbuena, Jana ;
Pachon, Gisela ;
Lopez-Torrents, Guillermo ;
Aran, Josep M. ;
Castresana, Javier S. ;
Petriz, Jordi .
CYTOMETRY PART A, 2011, 79A (09) :672-683
[9]   Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy [J].
Bartucci, M. ;
Svensson, S. ;
Romania, P. ;
Dattilo, R. ;
Patrizii, M. ;
Signore, M. ;
Navarra, S. ;
Lotti, F. ;
Biffoni, M. ;
Pilozzi, E. ;
Duranti, E. ;
Martinelli, S. ;
Rinaldo, C. ;
Zeuner, A. ;
Maugeri-Sacca, M. ;
Eramo, A. ;
De Maria, R. .
CELL DEATH AND DIFFERENTIATION, 2012, 19 (05) :768-778
[10]   A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours [J].
Beck, Benjamin ;
Driessens, Gregory ;
Goossens, Steven ;
Youssef, Khalil Kass ;
Kuchnio, Anna ;
Caauwe, Amelie ;
Sotiropoulou, Panagiota A. ;
Loges, Sonja ;
Lapouge, Gaelle ;
Candi, Aurelie ;
Mascre, Guilhem ;
Drogat, Benjamin ;
Dekoninck, Sophie ;
Haigh, Jody J. ;
Carmeliet, Peter ;
Blanpain, Cedric .
NATURE, 2011, 478 (7369) :399-+